BRD6989
BRD6989, an analog of the natural product cortistatin A (dCA), inhibits CDK8 and upregulates IL-10. BRD6989 selectively binds a complex of CDK8 with an IC50 of ~200 nM. BRD6989 inhibits the kinase activity of recombinant CDK8 or CDK19 complexes[1].
Product Specifications
CAS Number
642008-81-9
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CDK; Interleukin Related
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/brd6989.html
Purity
99.56
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
N#CC1=C(C2=CC=CN=C2)C3=C(N=C1N)CCC(C)C3
Molecular Formula
C16H16N4
Molecular Weight
264.33
Precautions
H302, H315, H319, H335
References & Citations
[1]Johannessen L, et al. Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. Nat Chem Biol. 2017 Oct;13 (10) :1102-1108
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK19; CDK8; IL-10
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse Cluster Of Differentiation 109 (CD109) ELISA Kit
Mouse Cluster Of Differentiation 109 (CD109) ELISA Kit
Mouse Cluster Of Differentiation 109 (CD109) ELISA Kit
Mouse Cluster Of Differentiation 109 (CD109) ELISA Kit